Circadian rhythms of heart rate and locomotion after treatment with low-dose acetylcholinesterase inhibitors

Journal of Applied Toxicology

Volumn 26, Issue 5, 2006, Pages 410-418

  Scremin, Oscar U ^a,c   Shih, Tsung Ming ^b   Huynh, Ly ^a   Roch, Margareth ^a   Sun, Wei ^a   Chialvo, Dante R ^a,c   Jenden, Donald J ^c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autonomic nervous system; Heart rate variability; Nerve agents; Pyridostigmine bromide; Sarin

Indexed keywords

CHOLINESTERASE INHIBITOR; PYRIDOSTIGMINE; SARIN; SODIUM CHLORIDE; TAP WATER;

ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; LETHAL DOSE; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RAT; TELEMETRY; VETERAN; WAR;

ANIMALS; CHOLINESTERASE INHIBITORS; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; LOCOMOTION; MALE; PERSIAN GULF SYNDROME; PYRIDOSTIGMINE BROMIDE; RATS; RATS, SPRAGUE-DAWLEY; SARIN; VETERANS;

ANIMALIA;

EID: 33748787454     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1155     Document Type: Article

References (42)

1. Basset A, Laude D, Laurent S, Elghozi JL. 2004. Contrasting circadian rhythms of blood pressure among inbred rat strains: recognition of dipper and non-dipper patterns. J. Hypertens. 22: 727-737.
2. Benessiano J, Levy B, Samuel JL, Leclercq JF, Safar M, Saumont R. 1983. Circadian changes in heart rate in unanesthetized normotensive and spontaneously hypertensive rats. Pflugers Arch. 397: 70-72.
3. Benstaali C, Mailloux A, Bogdan A, Auzeby A, Touitou Y. 2001. Circadian rhythms of body temperature and motor activity in rodents their relationships with the light-dark cycle. Life Sci. 68: 2645-2656.
4. Bernatova I, Dubovicky M, Price WA, Grubbs RD, Lucot JB, Morris M. 2003. Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacol. Biochem. Behav. 74: 901-907.
5. Brezenoff HE, Giuliano R. 1982. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu. Rev. Pharmacol. Toxicol. 22: 341-381.
6. Buccafusco JJ. 1996. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48: 179-211.
7. Chaney LA, Rockhold RW, Hume AS. 2002. Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m- toluamide (DEET) in rats. Int. J. Toxicol. 21: 287-300.
8. Cook MR, Graham C, Sastre A, Gerkovich MM. 2002. Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology (Berl.) 162: 186-192.
9. Doebbeling BN, Clarke WR, Watson D, Torner JC, Woolson RF, Voelker MD, Barrett DH, Schwartz DA. 2000. Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls. Am. J. Med. 108: 695-704.
10. Eastman CI, Gazda CJ, Burgess HJ, Crowley SJ, Fogg LF. 2005. Advancing circadian rhythms before eastward flight: a strategy to prevent or reduce jet lag. Sleep 28: 33-44.
11. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50: 219-244.
12. Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, Noah DL, Barrett DH, Randall B, Herwaldt BL, Mawle AC, Reeves WC. 1998. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 280: 981-988.
13. General Accounting Office. 2003. Gulf War illnesses: preliminary assessment of DOD plume modeling for U.S. troops' exposure to chemical agents GAO-03-833T. General Accounting Office; Washington, DC. www.gao.gov/cgi-bin/ getrpt?GAO-03-833T [12 May 2006].
14. Grauer E, Alkalai D, Kapon J, Cohen G, Raveh L. 2000. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol. Appl. Pharmacol. 164: 301-304.
15. Haley RW, Hom J, Roland PS, Bryan WW, Van Ness PC, Bonte FJ, Devous MD Sr, Mathews D, Fleckenstein JL, Wians FH, Jr., Wolfe GI, Kurt TL. 1997a. Evaluation of neurologic function in Gulf War veterans. A blinded case-control study. JAMA 277: 223-230.
16. Haley RW, Kurt TL, Horn J. 1997b. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277: 215-222.
17. Haley RW, Vongpatanasin W, Wolfe GI, Bryan WW, Armitage R, Hoffmann RF, Petty F, Callahan TS, Charuvastra E, Shell WE, Marshall WW, Victor RG. 2004. Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am. J. Med. 117: 469-478.
18. Hicks KK, Seifen E, Stimers JR, Kennedy RH. 1998. Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomie nervous control. J. Auton. Nerv. Syst. 69: 21-30.
19. Higgins CB, Vatner SF, Braunwald E. 1973. Parasympathetic control of the heart. Pharmacol. Rev. 25: 119-155.
20. Ismail K, Everitt B, Blatchley N, Hull L, Unwin C, David A, Wessely S. 1999. Is there a Gulf War syndrome? Lancet 353: 179-182.
21. Joaquim LF, Farah VM, Bernatova I, Fazan R, Jr., Grubbs R, Morris M. 2004. Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. Am. J. Physiol. Heart Circ. Physiol. 287: H251-H257.
22. Keeler JR, Hurst CG, Dunn MA. 1991. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 266: 693-695.
23. Kuo TB, Yang CC. 2004. Scatterplot analysis of EEG slow-wave magnitude and heart rate variability: an integrative exploration of cerebral cortical and autonomic functions. Sleep 27: 648-656.
24. Malliani A, Pagani M, Lombardi F, Cerutti S. 1991. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492.
25. McCauley LA, Rischitelli G, Lambert WE, Lasarev M, Sticker DL, Spencer PS. 2001. Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int. J. Occup. Environ. Health 7: 79-89.
26. Oosting J, Struijker-Boudier HA, Janssen BJ. 1997. Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats. J. Hypertens. 15: 401-410.
27. Pereira de Souza Neto E, Custaud M, Somody L, Gharib C. 2001. Assessment of autonomic cardiovascular indices in non-stationary data in rats. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 128: 105-115.
28. Petroianu G, Toomes LM, Petroianu A, Bergler W, Rufer R. 1998. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 18: 293-298.
29. Routledge HC, Chowdhary S, Townend JN. 2002. Heart rate variability - a therapeutic target? J. Clin. Pharm. Ther. 27: 85-92.
30. Sant'anna ID, de Sousa EB, de Moraes AV, Loures DL, Mesquita ET, da Nobrega AC. 2003. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. Clin. Sci. (Lond.) 105: 161-165.
31. Scremin OU, Allen K, Torres CD, Scremin AME. 1988. Physostigmine enhances blood flow metabolism ratio in neocortex. Neuropsychopharmacology 1: 297-303.
32. Scremin OU, Scremin AME, Heuser D, Hudgell R, Romero E, Imbimbo B. 1993. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats. J. Cereb. Blood Flow Metab. 13: 702-711.
33. Scremin OU, Shih T-M. 1991. Cerebral blood flow-metabolism coupling after administration of soman at nontoxic levels. Brain Res. Bull. 26, 353-356.
34. Scremin OU, Shih TM, Huynh L, Roch M, Booth R, Jenden DJ. 2003. Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors. J. Pharmacol. Exp. Ther. 304: 1111-1119.
35. Scremin OU, Shih TM, Huynh L, Roch M, Sun W, Chialvo DR, Jenden DJ. 2005. Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism. Pharmacol. Biochem. Behav. 80: 529-540.
36. Soares PP, da Nobrega AC, Ushizima MR, Irigoyen MC. 2004. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 113: 24-31.
37. Stein RD, Backman SB, Collier B, Polosa C. 1997. Bradycardia produced by pyridostigmine and physostigmine. Can. J Anaesth. 44: 1286-1292.
38. Timofeeva OA, Gordon CJ. 2002. EEG spectra, behavioral states and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos. Pharmacol. Biochem. Behav. 72: 669-679.
39. Varagic V. 1955. The action of eserine on the blood pressure of the rat. Br. J. Pharmacol. 10: 349-353.
40. Wang G, Fowler SC. 2001. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine. Psychopharmacology (Berl.) 158: 273-280.
41. Wolfe J, Proctor SP, Davis JD, Borgos MS, Friedman MJ. 1998. Health symptoms reported by Persian Gulf War veterans two years after return. Am. J. Ind. Med. 33: 104-113.
42. Yamamoto K, Shimizu M, Ohtani H, Hayashi M, Sawada Y, Iga T. 1996. Toxicodynamic analysis of cardiac effects induced by four cholinesterase inhibitors in rats. J. Pharm. Pharmacol. 48: 935-939.